Back to search

Central Florida

Two-Component Covalent Inhibitors (TCCI) of the Human Immunodeficiency Virus Reverse Transcriptase (HIV-RT)

Abstract

dc:description.abstract

The traditional design of nucleoside reverse transcriptase inhibitors (NRTI's) involves the synthesis of chain-terminated nucleoside analogs. HIV-RT has relatively low fidelity which facilitates mutations that confer resistance towards NRTI's, also, drug promiscuity from NRTI's result in various side-effects that lead to poor patient adherence to treatment. We designed and tested two-component covalent inhibitors against HIV-RT. Our inhibitor design results in higher specificity due to its binary approach, which has previously been used in biosensing applications, where both components are necessary for therapeutic effect, and lower chances for mutagenesis because of its inhibitory action. The TCCI approach results in up to 93% inhibition of HIV-RT Furthermore, our inhibitor design is highly modular and can be adjusted towards the therapeutic targeting of other biopolymers.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ledezma, Carlos
Contributors dc:contributor
  • Kolpashchikov, Dmitry

Subjects

dc:subject × 1

Rights

Language dc:language
English

Identifiers

dc:identifier.*
Identifier
CFE0006893

Chain of custody

source
Harvested from
Central Florida
Base URL
stars.library.ucf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ledezma, Carlos. Two-Component Covalent Inhibitors (TCCI) of the Human Immunodeficiency Virus Reverse Transcriptase (HIV-RT). https://stars.library.ucf.edu/etd/5707